1. Home
  2. HOMB vs PTCT Comparison

HOMB vs PTCT Comparison

Compare HOMB & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home BancShares Inc.

HOMB

Home BancShares Inc.

HOLD

Current Price

$27.86

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$74.88

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOMB
PTCT
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.7B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
HOMB
PTCT
Price
$27.86
$74.88
Analyst Decision
Buy
Buy
Analyst Count
4
17
Target Price
$31.50
$80.65
AVG Volume (30 Days)
1.4M
983.4K
Earning Date
04-15-2026
05-07-2026
Dividend Yield
3.17%
N/A
EPS Growth
19.90
264.48
EPS
0.60
N/A
Revenue
N/A
$264,734,000.00
Revenue This Year
$10.99
N/A
Revenue Next Year
$5.14
$17.70
P/E Ratio
$45.80
N/A
Revenue Growth
N/A
36.19
52 Week Low
$25.50
$43.18
52 Week High
$30.83
$87.50

Technical Indicators

Market Signals
Indicator
HOMB
PTCT
Relative Strength Index (RSI) 63.76 60.71
Support Level $27.80 $73.41
Resistance Level $28.59 $79.67
Average True Range (ATR) 0.42 2.66
MACD 0.15 0.39
Stochastic Oscillator 95.58 97.84

Price Performance

Historical Comparison
HOMB
PTCT

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: